E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 1/4/2024 in the Prospect News Structured Products Daily.

New Issue: Citigroup prices $1.25 million 13.25% autocallable contingent coupon notes on ETF, RTX shares

New York, Jan. 4 – Citigroup Global Markets Holdings Inc. priced $1.25 million of autocallable contingent coupon equity linked securities due July 2, 2026 linked to the RTX Corp. and SPDR S&P Biotech ETF, according to a 424B2 filing with the Securities and Exchange Commission.

Investors will receive a coupon of 13.25% paid quarterly if the worst performing asset closes at or above its 70% coupon barrier on the related valuation date.

The securities will be called automatically starting March 27, 2024 if the price of the worst performing asset is greater than or equal to its initial price and on any subsequent quarterly valuation date.

If the worst performing ETF finishes at or above its 70% final barrier the payout at maturity will be par. Otherwise investors will lose 1% loss for every 1% that the worst performing asset declines.

The notes are guaranteed by Citigroup Inc.

Citigroup Global Markets Inc. is the agent.

Issuer:Citigroup Global Markets Holdings Inc.
Guarantor:Citigroup Inc.
Issue:Autocallable contingent coupon equity linked securities
Underlying assets:RTX Corp. and SPDR S&P Biotech ETF
Amount:$1.25 million
Maturity:July 2, 2026
Coupon:13.25% paid quarterly if the worst performing asset closes at or above its 70% coupon barrier on the related valuation date
Price:Par
Payout at maturity:If worst performing asset finishes at or above final barrier par; 1% loss for every 1% that worst performing asset declines if it ends below final barrier
Call:Automatically starting March 27, 2024 if the price of the worst performing ETF is greater than or equal to its initial price and on any subsequent quarterly valuation date
Initial levels:$84.17 for RTX Corp., $90.83 for SPDR S&P Biotech ETF
Coupon barriers:$58.919 for RTX Corp., $63.581 for SPDR S&P Biotech ETF, 70% of initial levels
Final barriers:$58.919 for RTX Corp., $63.581 for SPDR S&P Biotech ETF, 70% of initial levels
Pricing date:Dec. 27
Settlement date:Dec. 29
Agent:Citigroup Global Markets Inc.
Fees:2.35%
Cusip:17291TWZ7

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.